NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 48 filers reported holding NEUBASE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $57,924 | -2.7% | 313,100 | 0.0% | 0.07% | -5.6% |
| Q4 2022 | $59,552 | -68.0% | 313,100 | -33.5% | 0.07% | -64.4% |
| Q3 2022 | $186,000 | -62.3% | 470,524 | 0.0% | 0.20% | -59.5% |
| Q2 2022 | $494,000 | -38.4% | 470,524 | +10.3% | 0.50% | +2.3% |
| Q1 2022 | $802,000 | -33.1% | 426,424 | 0.0% | 0.49% | -8.8% |
| Q4 2021 | $1,198,000 | -18.6% | 426,424 | +4.6% | 0.54% | 0.0% |
| Q3 2021 | $1,471,000 | -11.1% | 407,500 | +17.9% | 0.54% | -2.0% |
| Q2 2021 | $1,655,000 | -4.9% | 345,500 | +46.7% | 0.55% | -19.0% |
| Q1 2021 | $1,740,000 | +140.7% | 235,500 | +127.5% | 0.67% | +23.2% |
| Q4 2020 | $723,000 | – | 103,500 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 2,027,027 | $14,169,000 | 0.85% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 103,500 | $723,000 | 0.55% |
| Sio Capital Management, LLC | 293,699 | $2,053,000 | 0.42% |
| GSA CAPITAL PARTNERS LLP | 121,389 | $849,000 | 0.14% |
| Frontier Wealth Management LLC | 145,000 | $1,014,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $2,174,000 | 0.06% |
| Oak Grove Capital LLC | 19,175 | $134,000 | 0.04% |
| PREMIER ASSET MANAGEMENT LLC | 14,977 | $105,000 | 0.02% |
| Trexquant Investment LP | 15,479 | $108,000 | 0.01% |
| PILLAR PACIFIC CAPITAL MANAGEMENT LLC | 19,800 | $138,000 | 0.01% |